If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Toshihiro Miyamoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 23 Similar Profiles
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Peripheral Blood Stem Cell Transplantation Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Transplants Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma

Kodama, T., Kochi, Y., Nakai, W., Mizuno, H., Baba, T., Habu, K., Sawada, N., Tsunoda, H., Shima, T., Miyawaki, K., Kikushige, Y., Mori, Y., Miyamoto, T., Maeda, T. & Akashi, K., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 9, p. 1555-1564 10 p.

Research output: Contribution to journalArticle

G-Protein-Coupled Receptors
Multiple Myeloma
T-Lymphocytes
Antibodies
Therapeutics
2 Citations (Scopus)

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Peripheral Blood Stem Cell Transplantation
Dexamethasone
Therapeutics
lenalidomide

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

Sunami, K., Matsumoto, M., Fuchida, S. I., Omoto, E., Takamatsu, H., Adachi, Y., Choi, I., Fujishima, N., Kiguchi, T., Miyamoto, T., Maeda, A., Suzumiya, J., Yamamura, R., Nagafuji, K., Nakazato, T., Kuroda, Y., Yujiri, T., Takamatsu, Y., Harada, M. & Akashi, K., Jan 1 2019, In : International Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Cell Transplantation
Stem Cell Transplantation
Group Psychotherapy
Cell- and Tissue-Based Therapy
Multiple Myeloma
Phase II Clinical Trials
Clinical Trials, Phase I
Systemic Scleroderma
Hematopoietic Stem Cell Transplantation
Japan

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Nagafuji, K., Matsumura, I., Shimose, T., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Kadowaki, N., Ishikawa, J., Imamura, Y., Yamazaki, H., Akashi, K. & Kanakura, Y., Jan 1 2019, (Accepted/In press) In : International journal of hematology.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid, Chronic Phase
Therapeutics
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
Recurrence